首页> 外国专利> INHIBITION OF MIR-122 IN HEPATITIS C VIRUS INFECTED SUBJECTS AND CELLS

INHIBITION OF MIR-122 IN HEPATITIS C VIRUS INFECTED SUBJECTS AND CELLS

机译:MIR-122在肝炎病毒感染的受试者和细胞中的抑制作用

摘要

Methods and compositions for reducing viral genome amounts in a target cellare provided. In the subject methods, the activity of a miRNA is inhibited ina manner sufficient to reduce the amount of viral genome in the target cell,e.g., by introducing a miRNA inhibitory agent in the target cell. Alsoprovided are pharmaceutical compositions, kits and systems for use inpracticing the subject methods. The subject invention finds use in a varietyof applications, including the treatment of subjects suffering from a viralmediated disease condition, e.g., an HCV mediated disease condition.
机译:减少靶细胞中病毒基因组数量的方法和组合物提供。在主题方法中,miRNA的活性在一种足以减少靶细胞中病毒基因组数量的方法,例如,通过在靶细胞中引入miRNA抑制剂。也提供用于治疗的药物组合物,试剂盒和系统练习主题方法。本发明可用于多种用途的应用程序,包括对病毒感染者的治疗介导的疾病状况,例如HCV介导的疾病状况。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号